Skip to main content
SpringerLink
Log in

Immunohistochemistry (Selected Topics)

  • Chapter
Essentials of Diagnostic Breast Pathology

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

18.12 Further Reading

  1. Acs G, Lawton TJ, Rebbeck TR, et al. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol 2001;115:85–98.

    Article  PubMed  CAS  Google Scholar 

  2. Allred C, Harvey JM, Berado M, et al. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1999;11:155–168.

    Google Scholar 

  3. Barnes DM, Millis RR, Beex LV, et al. Increased use of immunohistochemistry for estrogen receptor measurement in mammary carcinoma: the need for quality assurance. Eur J Cancer 1998;34:1677–1682.

    Article  PubMed  CAS  Google Scholar 

  4. Bilous M, Ades C, Armes J, et al. Predicting the HER2 status of breast cancer from basic histopathology data: an analysis of 1500 breast cancers as part of the HER2000 International Study. Breast 2003;12:92–98.

    Article  PubMed  CAS  Google Scholar 

  5. Bocker W, Bier B, Freytag G, et al. An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen type IV and laminin. Part I. Virchows Arch (A) 1992;421:315–322.

    Article  CAS  Google Scholar 

  6. Bocker W, Bier B, Freytag G, et al. An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen type IV and laminin. Part II. Virchows Arch (A) 1992;421:323–330.

    Article  CAS  Google Scholar 

  7. Borg A, Tandon AK, Sigurdsson H, et al. HER2/neu amplification predicts poor survival in node positive breast cancer. Cancer Res 1990;50:4332–4337.

    PubMed  CAS  Google Scholar 

  8. Bratthauer GL, Moinfar F, Stamatakos MD, et al. Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias. Hum Pathol 2002;33:620–627.

    Article  PubMed  CAS  Google Scholar 

  9. Burstein HJ, Harris LN, Gelman R, et al. Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphoamide for HER2 overexpressing stage II or III breast cancer: a pilot study. J Clin Oncol 2003;21:46–53.

    Article  PubMed  CAS  Google Scholar 

  10. Chen PC, Chen CK, Nicastri AD, et al. Myoepithelial carcinoma of the breast with distant metastasis and accompanied by adenomyoepithelioma. Histopathology 1994;24:543–548.

    Article  PubMed  CAS  Google Scholar 

  11. Czerniecki BJ, Scheff AM, Callans LS, et al. Immunohistochemistry with pancytokeratins improves sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer 1999;85:1098–1103.

    Article  PubMed  CAS  Google Scholar 

  12. Dabbs DJ. Diagnostic immunohistochemistry of the breast. In: Diagnostic immunohistochemistry, 2002, Churchill Livingstone, New York

    Google Scholar 

  13. Diaz L, Sneige N. Estrogen receptor analysis for breast cancer. Current issues and keys to increasing testing accuracy. Adv Anat Pathol 2005;12:10–19.

    Article  PubMed  CAS  Google Scholar 

  14. Eusebi V, Foschini MP, Betts cm, et al. Microglandular adenosis, apocrine adenosis, and tubular carcinoma of the breast: an immunohistochemical comparison. Am J Surg Pathol 1993;17:99–109.

    Article  PubMed  CAS  Google Scholar 

  15. Eusebi V, Collina G, Bussolati G. Carcinoma in situ in sclerosing adenosis of the breast: an immunohistochemical study. Semin Diagn Pathol 1989;6:146–152.

    PubMed  CAS  Google Scholar 

  16. Fisher ER, Anderson S, Dean S, et al. Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinoma. Cancer 2005;103:164–173.

    Article  PubMed  CAS  Google Scholar 

  17. Fitzgibbons PL, Page DL, Weaver D, et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000;124:966–978.

    PubMed  CAS  Google Scholar 

  18. Foschini MP, Eusebi V. Carcinomas of the breast showing myoepithelial cell differentiation: a review of the literature. Virchows Arch 1998;432:303–310.

    Article  PubMed  CAS  Google Scholar 

  19. Goldhirsch A, Glick JH, Gelber RD, et al. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol 2001;19:3817–3827.

    PubMed  CAS  Google Scholar 

  20. Gottlieb C, Raju U, Greenwald KA. Myoepithelial cells in the differential diagnosis of complex benign and malignant breast lesions: an immunohistochemical study. Mod Pathol 1990;3:135–140.

    PubMed  CAS  Google Scholar 

  21. Jalava P, Kuopio T, Huovinen R, et al. Immunohistochemical staining of estrogen and progesterone receptors: aspects for evaluating positivity and defining the cutpoints. Anticancer Res 2005;25:2535–2542.

    PubMed  CAS  Google Scholar 

  22. Jolicoeur F, Gaboury LA, Oligny LL. Basal cells of second trimester fetal breasts: immunohistochemical study of myoepithelial precursors. Pediatr Dev Pathol 2003;6:398–413.

    Article  PubMed  CAS  Google Scholar 

  23. Joshi MG, Lee AKC, Pederson CA, et al. The role of immunocytochemical markers in the differential diagnosis of proliferative and neoplastic lesions of the breast. Mod Pathol 1996;9:57–62.

    PubMed  CAS  Google Scholar 

  24. Kaneko S, Gerasimova T, Butler WM, et al. The use of FISH on breast core needle samples for the presurgical assessment of Her-2 oncogene status. Exp Mol Pathol 2002;73:61–66.

    Article  PubMed  CAS  Google Scholar 

  25. Koker MM; Kleer CG. P63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma. Am J Surg Pathol 2004;28:1506–1512.

    Article  PubMed  Google Scholar 

  26. Leibl S, Denk H, Moinfar F. Metaplastic breast carcinomas: are they of myoepithelial differentiation? Immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers. Am J Surg Pathol 2005;29:347–353.

    Article  PubMed  Google Scholar 

  27. Liegl B, Horn LC, Moinfar F. Androgen receptors are frequently expressed in mammary and extramammary Paget’s disease. Mod Pathol 2005;18:1283–1288.

    Article  PubMed  CAS  Google Scholar 

  28. McCann J. Better assays needed for hormone receptor status, experts say. J Natl Cancer Inst 2001;93:579–580.

    Article  PubMed  CAS  Google Scholar 

  29. Moinfar F, Man YG, Lininger RA, et al. Use of keratin 34BE12 as an adjunct in the diagnosis of mammary intraepithelial neoplasia-ductal type. Am J Surg Pathol 1999;23:1048–1058.

    Article  PubMed  CAS  Google Scholar 

  30. Mueller-Holzner E, Fink V, Frede T, Marth C. Immunohistochemical determination of HER2 expression in breast cancer from core biopsy specimens: a reliable predictor of HER2 status of the whole tumor. Breast Cancer Res Treat 2001;69:13–19.

    Article  PubMed  CAS  Google Scholar 

  31. Muss HB, Thor AD, Berry DA, et al. C-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N Engl J Med 1994;330:1260–1266.

    Article  PubMed  CAS  Google Scholar 

  32. Nadji M, Gomez-Fernandez C, Ganjei-Azar P, Morales AR. Immunohistochemistry of estrogen and progesterone receptors reconsidered. Experience with 5.993 breast cancer. Am J Clin Pathol 2005;123:21–27.

    Article  PubMed  Google Scholar 

  33. Nagle RB, Bocker W, Davis JR, et al. Characterization of breast carcinomas by two monoclonal antibodies distinguishing myoepithelial from luminal epithelial cells. J Histochem Cytochem 1986;34:869–881.

    PubMed  CAS  Google Scholar 

  34. Ogawa Y, Moriya T, Kato Y, et al. Immunohistochemical assessment for estrogen receptor and progesterone receptor status in breast cancer: analysis for a cut-off point as the predictor for endocrine therapy. Breast Cancer 2004;11:267–275.

    Article  PubMed  Google Scholar 

  35. Quenel N, Wafflart J, Bonichon F, et al. The prognostic value of c-erbB2 in primary breast carcinomas: A study of 942 cases. Breast Cancer Res Treat 1995;35:283–291.

    Article  PubMed  CAS  Google Scholar 

  36. Raju U, Crissman JD, Zarbo RJ, et al. Epitheliosis of the breast: An immunohistochemical characterization and comparison to malignant intraductal proliferation of the breast. Am J Surg Pathol 1990;14:939–947.

    Article  PubMed  CAS  Google Scholar 

  37. Raju U, Lee MW, Zarbo RJ, et al. Papillary neoplasia of the breast: immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms. Mod Pathol 1989;2:569–576.

    PubMed  CAS  Google Scholar 

  38. Regitnig P, Reiner A, Dinges HP, et al. Quality assurance for detection of estrogen and progesterone receptors by immunohistochemistry in Austrian pathology laboratories. Virchows Arch 2002;441:328–334.

    Article  PubMed  CAS  Google Scholar 

  39. Reiner A, Reiner G, Spona J, et al. Histopathologic characterization of human breast cancer in correlation with estrogen receptor status: a comparison of immunocytochemical and biochemical analysis. Cancer 1988:64:1149–1154.

    Article  Google Scholar 

  40. Reis-Filho JS, Simpson PT, Martins A, et al. Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Arch 2003;443:122–32.

    Article  PubMed  CAS  Google Scholar 

  41. Reis-Filho JS, Steele D, Di Palma S, et al. Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue. Mod Pathol 2006;19:307–319.

    Article  PubMed  CAS  Google Scholar 

  42. Remmele W, Schiketanz KH. Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer: computer-assisted image analysis. Pathol Res Pract 1993;189:862–866.

    PubMed  CAS  Google Scholar 

  43. Rhodes A, Jasani B, Barnes DM, et al. Reliability of immunohistochemical demonstration of estrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring system. J Clin Pathol 2000;53:125–130.

    Article  PubMed  CAS  Google Scholar 

  44. Rhodes A, Jasani B, Balaton AJ, et al. Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe. Documentation of poor reliability and identification of insufficient microwave antigen retrieval times as a major contributory element of unreliable assays. Am J Clin Pathol 2001;115:44–58.

    Article  PubMed  CAS  Google Scholar 

  45. Rhodes A, Jasani B, Balaton AJ, et al. Immunohistochemical demonstration of estrogen and progesterone receptors: correlation of standards achieved on in house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries. J Clin Pathol 2000;53:292–301.

    Article  PubMed  CAS  Google Scholar 

  46. Simpson RH, Cope N, Skalova, et al. Malignant adenomyoepithelioma of the breast with mixed osteogenic, spindle cell and carcinomatous differentiation. Am J Surg Pathol 1998;22:631–636.

    Article  PubMed  CAS  Google Scholar 

  47. Sobin LH, Wittekind CH. TNM classification of malignant tumors, 6th edn. John Wiley & Sons, Hoboken, NJ, 2002.

    Google Scholar 

  48. Stefanou D, Batistatou A, Nonni A, et al. P63 expression in benign and malignant breast lesions. Histol Histopathol 2004;19:465–471.

    PubMed  CAS  Google Scholar 

  49. Steinhoff MM. Axillary node micrometastases: detection and biologic significance. Breast J 1999;5:325–329.

    Article  PubMed  Google Scholar 

  50. Tavassoli FA. Myoepithelial lesions of the breast: myoepitheliosis, adenomyoepithelioma and myoepithelial carcinoma. Am J Surg Pathol 1991;15:554–568.

    Article  PubMed  CAS  Google Scholar 

  51. Tavassoli FA. Pathology of the breast. Appleton & Lange, Stamford, CT, 1999.

    Google Scholar 

  52. Tavassoli FA, Devilee P (eds). World Health Organization classification of tumours. Pathology and genetics. Tumours of the breast and female genital organs. IARC Press, Lyon, 2003.

    Google Scholar 

  53. Van Diest PJ, Weger DR, Lindhol J, et al. Reproducibility of subjective immunoscoring of steroid receptors in breast cancer. Anal Quant Cytol Histol 1996;18:351–354.

    PubMed  Google Scholar 

  54. Vincent-Salomon A, MacGrogan G, Couturier J, et al. Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French multicenter GEEPICS study. Histopathology 2003;42:337–347.

    Article  PubMed  CAS  Google Scholar 

  55. Wang NP, Wan BC, Skelly M, et al. Antibodies to novel myoepithelium-associated proteins distinguish benign lesions and carcinoma in situ from invasive carcinoma of the breast. Appl Immunohistochem 1997;5:141–151.

    Article  Google Scholar 

  56. Wick MR, Lillemore TJ, Copland GT, et al. Gross cystic disease fluid protein-15 as a marker for breast cancer: Immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. Hum Pathol 1989;20:281–287.

    Article  PubMed  CAS  Google Scholar 

  57. Zhang RR, Man YG, Vang R, et al. A subset of morphologically distinct mammary myoepithelial cells lacks corresponding immunophenotypic markers. Breast Cancer Res 2002;5:R151–156.

    Article  CAS  Google Scholar 

  58. Zidan A, Christie Brown JS, Peston D, et al. Estrogen and progesterone receptor assessment in core biopsy specimens of breast carcinoma. J Clin Pathol 1997;50:27–29.

    Article  PubMed  CAS  Google Scholar 

Download references

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

(2007). Immunohistochemistry (Selected Topics). In: Essentials of Diagnostic Breast Pathology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-45120-4_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-45120-4_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-45117-4

  • Online ISBN: 978-3-540-45120-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation